Financial results - DIANA PHARMAX S.R.L.

Financial Summary - Diana Pharmax S.r.l.
Unique identification code: 4677290
Registration number: J23/2993/2024
Nace: 6820
Sales - Ron
2.161.495
Net Profit - Ron
27.459
Employees
13
Open Account
Company Diana Pharmax S.r.l. with Fiscal Code 4677290 recorded a turnover of 2021 of 2.161.495, with a net profit of 27.459 and having an average number of employees of 13. The company operates in the field of Închirierea şi subînchirierea bunurilor imobiliare proprii sau închiriate having the NACE code 6820.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Diana Pharmax S.r.l.

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR 1.162.040 1.626.647 1.830.949 1.813.873 1.933.420 2.123.730 2.173.511 - - -
Total Income - EUR 1.163.837 1.629.925 1.834.445 1.816.836 1.935.913 2.127.612 2.175.197 - - -
Total Expenses - EUR 1.068.628 1.577.978 1.681.684 1.682.260 1.798.676 1.950.846 2.138.754 - - -
Gross Profit/Loss - EUR 95.209 51.948 152.761 134.577 137.237 176.766 36.443 - - -
Net Profit/Loss - EUR 89.453 43.636 150.865 109.380 117.200 156.458 27.612 - - -
Employees 10 14 13 12 13 13 13 - - -
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales increased by 4.7%, from 2.123.730 euro in the year 2020, to 2.173.511 euro in 2021. The Net Profit decreased by -125.376 euro, from 156.458 euro in 2020, to 27.612 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Diana Pharmax S.r.l.

Rating financiar

Financial Rating -
DIANA PHARMAX S.R.L.

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Diana Pharmax S.r.l.

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Diana Pharmax S.r.l.

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Diana Pharmax S.r.l.

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Diana Pharmax S.r.l. - CUI 4677290

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets 81.287 73.707 112.305 100.140 117.224 99.153 83.512 - - -
Current Assets 458.524 950.575 768.414 1.069.246 961.873 1.350.699 1.668.788 - - -
Inventories 119.629 142.280 217.970 264.368 324.850 432.492 371.843 - - -
Receivables 304.444 719.631 494.110 795.080 634.642 911.466 1.234.191 - - -
Cash 34.452 88.664 56.334 9.798 2.380 6.741 62.754 - - -
Shareholders Funds 190.079 231.776 378.719 431.724 530.027 676.437 689.047 - - -
Social Capital 45 45 44 43 42 41 40 - - -
Debts 349.733 792.505 502.116 737.933 549.434 773.564 1.063.512 - - -
Income in Advance 0 0 0 0 0 0 0 - - -
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "6820 - 6820"
CAEN Financial Year 6820
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 1.668.788 euro in 2021 which includes Inventories of 371.843 euro, Receivables of 1.234.191 euro and cash availability of 62.754 euro.
The company's Equity was valued at 689.047 euro, while total Liabilities amounted to 1.063.512 euro. Equity increased by 27.612 euro, from 676.437 euro in 2020, to 689.047 in 2021.

Risk Reports Prices

Reviews - Diana Pharmax S.r.l.

Comments - Diana Pharmax S.r.l.

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.